Feasibility, acceptability and preliminary evaluation of a user co-facilitated psychoeducational programme: a feasibility proof-of-concept randomised control trial.
| Title: | Feasibility, acceptability and preliminary evaluation of a user co-facilitated psychoeducational programme: a feasibility proof-of-concept randomised control trial. |
|---|---|
| Authors: | Skliarova T; Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. tatiana.skliarova@ntnu.no.; Lara-Cabrera ML; Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Nidelv Community Mental Health Centre, Department of Mental Healthcare, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Hafstad H; Vårres Regional User-Led Center Mid-Norway, Trondheim, Norway.; Havnen A; Nidaros Community Mental Health Center, Division of Psychiatry, St. Olavs University Hospital, Trondheim, Norway.; Department of Psychology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Saether SG; Blue Cross Lade Addiction Treatment Centre, Trondheim, Norway.; Salvesen Ø; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.; Vaag J; Department of Psychology, Inland University of Applied Sciences, Lillehammer, Norway.; Torgersen T; Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Nidelv Community Mental Health Centre, Department of Mental Healthcare, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. |
| Source: | BMC psychiatry [BMC Psychiatry] 2024 Sep 16; Vol. 24 (1), pp. 615. Date of Electronic Publication: 2024 Sep 16. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Language: | English |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: London : BioMed Central, [2001- |
| MeSH Terms: | Attention Deficit Disorder with Hyperactivity*/therapy ; Attention Deficit Disorder with Hyperactivity*/psychology ; Patient Satisfaction* ; Proof of Concept Study*; Patient Acceptance of Health Care/psychology ; Patient Education as Topic/methods ; Psychotherapy, Group/methods ; Quality of Life/psychology ; Adult ; Female ; Humans ; Male ; Middle Aged ; Feasibility Studies ; Norway ; Self Efficacy |
| Abstract: | Background: Mental health settings are increasingly using co-facilitation of educational group interventions in collaboration with patient partners and service users. However, despite promising results, limited information is available regarding the feasibility and satisfaction levels of these programmes among adults newly diagnosed with attention-deficit hyperactivity/impulsivity disorder (ADHD). Hence, this study aimed to determine the feasibility, acceptability, and preliminary effects of a user co-facilitated psychoeducational group programme for adults diagnosed with ADHD.; Methods: This feasibility proof-of-concept randomised controlled trial recruited outpatients from a Norwegian community mental health centre. Outpatients randomised to the intervention group (IG) received a psychoeducational programme supplementing Treatment As Usual (TAU), while the control group received TAU. Feasibility was determined by the acceptance rate, adherence rate, and dropout rate. Acceptability was measured with the Client Satisfaction Questionnaire and a 3-item scale measuring satisfaction with the received information. To test the preliminary effects, self-efficacy, symptom severity, and quality of life were measured at baseline and pre- and post-intervention.; Results: Feasibility was demonstrated; most of the patients were willing to enrol, participants attended 82% of the psychoeducational programme, and only 13% dropped out of the study. The between-group analyses revealed that the IG reported significantly greater mean satisfaction than the CG. Moreover, the intervention group was more satisfied with the information they received during the psychoeducational programme. Concerning the preliminary effects, the linear mixed model showed improvement in quality of life (the subscale relationship); however, other patient-reported outcomes did not show improvements.; Conclusions: This proof-of-concept randomised controlled trial supports the feasibility and acceptability of the user co-facilitated psychoeducational programme for patients newly diagnosed with ADHD in an outpatient setting. While preliminary findings indicate promise in enhancing patient-reported outcomes, a larger study is warranted to assess the intervention's effectiveness rigorously.; Trial Registration: NCT03425, 09/11/2017.; (© 2024. The Author(s).) |
| References: | Atten Defic Hyperact Disord. 2010 Jun;2(2):59-72. (PMID: 21432591); Psychiatr Serv. 2013 Dec 1;64(12):1211-7. (PMID: 23999845); BMC Psychiatry. 2024 Jun 20;24(1):463. (PMID: 38902683); BMC Psychiatry. 2013 Mar 28;13:104. (PMID: 23537095); J Altern Complement Med. 2021 Mar;27(S1):S37-S44. (PMID: 33788603); JCPP Adv. 2022 Jul 10;2(3):e12090. (PMID: 37431386); Schizophr Res. 2010 May;118(1-3):264-70. (PMID: 20185272); Eur Psychiatry. 2017 Jul;44:141-152. (PMID: 28641216); Atten Defic Hyperact Disord. 2015 Jun;7(2):141-50. (PMID: 25563210); Eur Arch Psychiatry Clin Neurosci. 2012 Sep;262(6):519-28. (PMID: 22212725); Qual Life Res. 2006 Feb;15(1):117-29. (PMID: 16411036); Health Expect. 2022 Oct;25(5):2593-2602. (PMID: 35999687); BMC Med. 2024 Feb 29;22(1):72. (PMID: 38418998); J Atten Disord. 2019 Jan;23(1):99-108. (PMID: 26088028); Res Involv Engagem. 2023 Aug 30;9(1):72. (PMID: 37649111); BMC Psychiatry. 2017 Aug 22;17(1):302. (PMID: 28830387); Psychiatr Serv. 2018 May 1;69(5):529-535. (PMID: 29385952); Patient Educ Couns. 2016 May;99(5):760-8. (PMID: 26682971); Isr J Psychiatry Relat Sci. 2010;47(4):308-15. (PMID: 21270505); Psychiatr Rehabil J. 2013 Dec;36(4):278-88. (PMID: 24219769); J Atten Disord. 2009 Jan;12(4):353-60. (PMID: 18367759); BMC Med. 2010 Mar 24;8:18. (PMID: 20334633); J Atten Disord. 2017 Apr;21(6):533-539. (PMID: 25300813); Arch Gen Psychiatry. 2005 Jun;62(6):617-27. (PMID: 15939839); Front Psychol. 2022 Aug 22;13:893469. (PMID: 36072032); Psychol Rep. 2019 Dec;122(6):2074-2095. (PMID: 30235979); Psychol Med. 2005 Feb;35(2):245-56. (PMID: 15841682); Patient Educ Couns. 2016 Jul;99(7):1257-1261. (PMID: 26905956); Adm Policy Ment Health. 2023 Mar;50(2):296-316. (PMID: 36396756); Eur Arch Psychiatry Clin Neurosci. 2018 Jun;268(4):321-335. (PMID: 29356899); Brain Behav. 2020 Jun;10(6):e01605. (PMID: 32285644); Psychosoc Med. 2013;10:Doc01. (PMID: 23429426); OTJR (Thorofare N J). 2015 Jul;35(3):169-77. (PMID: 26594739); Int J Ment Health Nurs. 2018 Apr;27(2):911-921. (PMID: 28994234); BMC Health Serv Res. 2018 Aug 29;18(1):665. (PMID: 30157839); Front Psychiatry. 2023 Nov 06;14:1212961. (PMID: 38025439); BMC Health Serv Res. 2017 Jan 26;17(1):88. (PMID: 28126032); BMC Psychiatry. 2010 Sep 03;10:67. (PMID: 20815868); Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65. (PMID: 27866355); Psychiatr Rehabil J. 2016 Mar;39(1):62-7. (PMID: 26461435); BMC Psychiatry. 2022 Jun 2;22(1):375. (PMID: 35655149); Psychiatr Q. 2018 Jun;89(2):293-305. (PMID: 28948424); J Ment Health. 2023 Feb;32(1):307-320. (PMID: 32954909); J Nerv Ment Dis. 2013 Oct;201(10):894-900. (PMID: 24080677); BMC Psychiatry. 2023 Nov 7;23(1):808. (PMID: 37936112); J Psychiatr Ment Health Nurs. 2021 Oct;28(5):873-899. (PMID: 34311508); J Atten Disord. 2012 Oct;16(7):544-52. (PMID: 21725028); CMAJ. 2003 Mar 18;168(6):715-22. (PMID: 12642429); Internet Interv. 2023 Mar 20;32:100614. (PMID: 36969389); Health Expect. 2023 Aug;26(4):1453-1466. (PMID: 37292036); Am J Public Health. 2010 Feb;100(2):247-53. (PMID: 20019321); Internet Interv. 2021 Nov 20;26:100485. (PMID: 34877262); J Atten Disord. 2009 Mar;12(5):434-41. (PMID: 18310557); Arch Clin Neuropsychol. 2010 May;25(3):157-73. (PMID: 20197297); BMC Psychiatry. 2024 Jan 25;24(1):73. (PMID: 38273266); J Child Psychol Psychiatry. 2023 Jun;64(6):848-858. (PMID: 36651107); JMIR Mhealth Uhealth. 2017 Jul 20;5(7):e94. (PMID: 28729235); BMC Health Serv Res. 2016 Sep 22;16(1):513. (PMID: 27659102); J Affect Disord. 2013 Mar 5;145(3):386-93. (PMID: 22858264); Health Res Policy Syst. 2020 Feb 11;18(1):17. (PMID: 32046728); Eur Psychiatry. 2019 Feb;56:14-34. (PMID: 30453134); Pilot Feasibility Stud. 2019 Jan 23;5:17. (PMID: 30693097); Psychiatr Serv. 2013 Jan;64(1):51-7. (PMID: 23070062); Nord J Psychiatry. 2006;60(1):38-43. (PMID: 16500798); J Atten Disord. 2008 May;11(6):720-7. (PMID: 17968028); Appl Neuropsychol Adult. 2023 Jan-Feb;30(1):71-82. (PMID: 33905287); Patient Educ Couns. 2023 Sep;114:107858. (PMID: 37348313); J Atten Disord. 2019 Jul;23(9):931-939. (PMID: 27033881); J Atten Disord. 2016 Mar;20(3):279-90. (PMID: 23074301); Arch Gen Psychiatry. 1991 Jan;48(1):77-83. (PMID: 1984764); J Atten Disord. 2010 Mar;13(5):524-31. (PMID: 19395647); J Atten Disord. 2009 Sep;13(2):175-87. (PMID: 19372500); Atten Defic Hyperact Disord. 2015 Mar;7(1):89-99. (PMID: 24863143); Psychiatr Serv. 2019 Jan 1;70(1):19-25. (PMID: 30353790); Am J Psychiatry. 2006 Apr;163(4):716-23. (PMID: 16585449); J Clin Psychiatry. 2007;68 Suppl 2:42-8. (PMID: 17288507) |
| Contributed Indexing: | Keywords: Adult ADHD; Co-creation; Feasibility; Group treatment; Patient education; Patient satisfaction; Peer co-led; Psychoeducation; Randomised controlled trial; Self-efficacy; Self-management; User-centred design |
| Molecular Sequence: | ClinicalTrials.gov NCT00003425 |
| Entry Date(s): | Date Created: 20240916 Date Completed: 20240917 Latest Revision: 20250227 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC11403850 |
| DOI: | 10.1186/s12888-024-06015-4 |
| PMID: | 39285365 |
| Database: | MEDLINE |
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't